Antech™ Expands trūRapid™ FOUR and trūRapid™ FIV/FeLV Rapid Tests to Canada After CFIA Approval
Antech™ Expands trūRapid™ FOUR and trūRapid™ FIV/FeLV Rapid Tests to Canada After CFIA Approval Global finance never sleeps. Every day, […]
Spanish Mountain Gold Initiates Ore Sorting Work on Gold Mineralization
Spanish Mountain Gold Initiates Ore Sorting Work on Gold Mineralization Global finance never sleeps. Every day, investors across the US,
Spanish Mountain Gold Initiates Ore Sorting Work on Gold Mineralization Read Post »
SINTX Technologies Receives FDA Clearance for SINAPTIC® Foot & Ankle Implant System
SINTX Technologies Receives FDA Clearance for SINAPTIC® Foot & Ankle Implant System Global finance never sleeps. Every day, investors across
SINTX Technologies Receives FDA Clearance for SINAPTIC® Foot & Ankle Implant System Read Post »
With Apple stock near a record high as earnings loom, here’s the options trade to make
The iPhone maker’s shares tend to rise in the last 3 months of the year, says Evercore
With Apple stock near a record high as earnings loom, here’s the options trade to make Read Post »
Bloomberg Brief 10/20/2025 (Video)
Bloomberg Brief 10/20/2025 (Video) Global finance never sleeps. Every day, investors across the US, UK, Canada, Australia, Europe, and Brazil
US Futures Rise as Investors Turn Gaze to Earnings: Markets Wrap
US Futures Rise as Investors Turn Gaze to Earnings: Markets Wrap Global finance never sleeps. Every day, investors across the
US Futures Rise as Investors Turn Gaze to Earnings: Markets Wrap Read Post »
TELUS Digital Reminds Shareholders to Vote IN FAVOUR of Arrangement with TELUS Corporation
TELUS Digital Reminds Shareholders to Vote IN FAVOUR of Arrangement with TELUS Corporation Global finance never sleeps. Every day, investors
AstraZeneca hails major breakthroughs with breast-cancer drugs
An executive at AstraZeneca says breast-cancer drugs that the company highlighted at an industry conference over the weekend could represent
AstraZeneca hails major breakthroughs with breast-cancer drugs Read Post »
Priner (PRNR3) conclui compra de 60% da SEMEP
Priner (PRNR3) conclui compra de 60% da SEMEP Global finance never sleeps. Every day, investors across the US, UK, Canada,